Jump to content

Albert Zwaveling

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by WikiCleanerBot (talk | contribs) at 08:29, 16 November 2020 (v2.04b - Bot T20 CW#61 - WP:WCW project (Reference before punctuation)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Albert Zwaveling
Born (1927-07-21) 21 July 1927 (age 97)
Schoonebeek, Netherlands
NationalityDutch
EducationLeiden University Medical Center (PhD)
Known forFounder of surgical oncology in the Netherlands
Scientific career
FieldsSurgical oncology
InstitutionsLeiden University Medical Center
Thesis Implantatie-metastasen : chemotherapeutische prophylaxe en groei in geïnfecteerd milieu  (1960)

Albert Zwaveling (born 21 July 1927) is a Dutch surgeon specializing in oncology, who worked as a professor at Leiden University between 1972 and 1992. He implemented chemotherapy in Dutch surgery [1][2] and is considered to be one of the founders of surgical oncology in the Netherlands.[3][4]

Career

Albert Zwaveling was born on 21 July 1927 in Schoonebeek, in the province of Drenthe, the Netherlands.[5] He worked as a doctor on the island of Ternate in Indonesia before returning to the Netherlands. In July 1958 he started a surgical residency at the department of surgery of the Leiden University Medical Center under professor Maarten Vink.[6]

In 1960 Zwaveling obtained his PhD at Leiden University on the subject of experimental chemotherapeutical treatment of implantation metastases with a thesis titled: "Implantatie-metastasen : chemotherapeutische prophylaxe en groei in geïnfecteerd milieu".[1] At the time, these were the first research papers on cancer chemotherapy in the Netherlands and led to the clinical implementation of chemotherapy in Dutch surgery.[2][3][6] Vink and Zwaveling published the pivotal paper ‘Chancing Concepts in Cancer Surgery”in 1962.[3] In addition to regular cancerchemotherapy isolated perfusion was introduced, followed by intra-arterial infusion two years later.[6] In 1963 Zwaveling followed a one-year fellowship at the surgical department of the UW Health University Hospital in Madison, Wisconsin (USA) for one year to be familiarized with American surgical procedures and the use of chemotherapy in surgery.[6] Zwaveling became a lector of surgery, specializing in clinical oncology, at Leiden University in 1968 and was appointed a full professor of surgical oncology in 1972.[6]

In 1971, together with radiotherapist professor Piet Thomas and Emile van Slooten, surgeon at the Antoni van Leeuwenhoekziekenhuis, Zwaveling published the first breast cancer treatment protocol in the Netherlands.[7] Moreover, in 1973 he initiated the first national multicenter randomized trial on adjuvant chemotherapy in breastcancer.[8] Along with publishing scientific papers, he was actively involved in the training of students, residents and surgeons. To this purpose, Zwaveling wrote and co-edited multiple textbooks and educational articles. The textbook Oncology (co-edited with the sociologist R.van Zonneveld) appeared in 1973 and the first Dutch textbook of general surgery (Leerboek Chirurgie) was published in 1983.[9][10] Because of these achievements Zwaveling is considered one of the founders of surgical oncology in the Netherlands, together with his colleagues professor Jan Oldhoff of the University Medical Center Groningen and Emile van Slooten. In 1981 their efforts led to the establishment of the “Dutch society of Surgical Oncology”, of which they became honorary members in 1991.[4][6] In 1981 Zwaveling succeeded Vink as Head of the department of surgery in Leiden. His teaching assignment was then broadened to general surgery and the surgical oncology section came to be headed by professor Kees Welvaart and professor Cornelis van de Velde.[6] Zwaveling retired from his clinical work in 1992.[5] Until 2010 he worked as a medical adviser and interim manager and, in this context, advised on establishing the new specialism Technical Medicine at the University of Twente.[11]

Zwaveling was elected a member of the Royal Netherlands Academy of Arts and Sciences in 1979.[12] In 1992 he was made Knight in the Order of the Netherlands Lion.[13]

References

  1. ^ a b A. Zwaveling, PhD thesis Leiden University, 1960 “Implantation Metatasis. Chemotherapeutic Prophylaxis and Tumorgrowth in an Infected Milieu”
  2. ^ a b A. Zwaveling, E. Stenfert Kroese, H. E. van Gilse “Praktische handleiding voor kankerchemotherapie” H.E. Stenfert Kroese, Leiden. First ed.1966
  3. ^ a b c M.Vink, A. Zwaveling. “Chancing Concepts in Cancer Surgery” Arch Chir Neerland Vol XIV Fasc 3 1962
  4. ^ a b D. Busman et al. “Canon van de Heelkunde; 57 vensters van de heelkunde der Lage Landen” Paragraph 41, p 88 & 89: “Chirurgische Oncologie”, ISBN 978 94 908 2630 7
  5. ^ a b "Albert Zwaveling" (in Dutch). Leiden University. Archived from the original on 11 April 2020.
  6. ^ a b c d e f g "Hoe het was: een wandeling door 35 jaar Leidse heelkunde" (PDF) (in Dutch). Leidse Alumnivereniging Geneeskunde. January 2011. Archived from the original (PDF) on 11 April 2020.
  7. ^ ”Richtlijnen behandeling mammacarcinoom” Stichting Koningin Wilhelminafonds Nederlandse Organisatie voor de Kankerbestrijding, Amsterdam, 1971
  8. ^ O.J. Repelaer van Driel, PhD thesis Leiden University, 1987 “Adjuvante chemotherapie bij mammacarcinoom” ISBN 90 900 1876 X
  9. ^ A. Zwaveling, R. van Zonneveld “Oncologie” Stafleu Leiden, 1971, ISBN 90 6016 561 6
  10. ^ J. De Boer, F. Derom, J.A. Gruwez, J. Kuijjer, G. den Otter, A.Zwaveling “Leerboek Chirurgie” Bohn, Scheltema en Holkema, 1983 First ed. ISBN 90 313 0583 9
  11. ^ "Perspectief voor UT "goes medical"". utoday.nl (in Dutch). 11 December 2006. Archived from the original on 20 September 2020.
  12. ^ "Albert Zwaveling". Royal Netherlands Academy of Arts and Sciences. Archived from the original on 11 April 2020.
  13. ^ "Personalia". Nederlands Tijdschrift voor Geneeskunde. 21 July 1992. Archived from the original on 16 August 2020.